Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
2019 · JAMA · 814 citations
https://doi.org/10.1001/jama.2019.8145
H
Hirotoshi Watanabe
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
206
Papers
4.4K
Citations
30
h-index
76
i10-index
Hirotoshi Watanabe is an academic researcher from Municipal Hirakata City Hospital. The author has contributed to research in topics: Coronary Interventions and Diagnostics & Antiplatelet Therapy and Cardiovascular Diseases & Acute Myocardial Infarction Research. The author has an h-index of 30, co-authored 176 publications.
ORCID: 0000-0002-9443-5915Papers by this author
worksDerivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention
2024 · Circulation · 65 citations
https://doi.org/10.1161/circulationaha.124.072009
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis
2025 · The Lancet · 40 citations
https://doi.org/10.1016/s0140-6736(25)01562-4
Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention
2013 · Cardiovascular Diabetology · 26 citations
https://doi.org/10.1186/1475-2840-12-74
Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation Drug-Eluting Stents
2021 · JACC Asia · 5 citations
https://doi.org/10.1016/j.jacasi.2021.08.010
Single-Session Versus Staged Multivessel Optimal IVUS-Guided PCI in Patients With CCS or NSTE-ACS
2023 · JACC Asia · 5 citations
https://doi.org/10.1016/j.jacasi.2023.03.013
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat